HK Stock MarketDetailed Quotes

AIM VACCINE (06660)

Watchlist
  • 3.730
  • -0.010-0.27%
Noon Break Jan 16 11:52 CST
4.58BMarket Cap-15.48P/E (TTM)

AIM VACCINE (06660) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2025
(FY)Dec 31, 2024
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
Turnover
-4.19%514.66M
8.22%1.29B
-0.61%537.18M
-6.06%1.19B
--540.47M
-19.49%1.26B
-4.14%1.57B
26.53%672.56M
72.12%1.64B
--531.56M
Operating income
-4.19%514.66M
8.22%1.29B
-0.61%537.18M
-6.06%1.19B
540.47M
-19.49%1.26B
-4.14%1.57B
26.53%672.56M
72.12%1.64B
531.56M
Cost of sales
-16.48%-173.42M
-15.73%-331.52M
-38.09%-148.89M
-21.17%-286.45M
---107.82M
14.17%-236.41M
2.98%-275.43M
-16.74%-124.08M
-29.74%-283.88M
---106.29M
Operating expenses
-16.48%-173.42M
-15.73%-331.52M
-38.09%-148.89M
-21.17%-286.45M
-107.82M
14.17%-236.41M
2.98%-275.43M
-16.74%-124.08M
-29.74%-283.88M
-106.29M
Gross profit
-12.12%341.24M
5.83%953.51M
-10.25%388.29M
-12.32%901.02M
432.65M
-20.63%1.03B
-4.39%1.29B
28.97%548.48M
84.77%1.35B
425.27M
Selling expenses
0.08%-232.06M
-9.85%-542.67M
-3.26%-232.24M
-0.17%-494M
---224.9M
-7.18%-493.17M
13.71%-460.11M
-29.33%-228.83M
-61.59%-533.25M
---176.94M
Administrative expenses
-1.68%-126.25M
-11.18%-282.73M
-7.35%-124.16M
43.59%-254.29M
---115.66M
61.41%-450.76M
-487.82%-1.17B
-1,049.55%-1.03B
-26.41%-198.7M
---89.23M
Research and development expenses
37.12%-106.96M
42.94%-363.13M
57.32%-170.11M
-27.20%-636.4M
---398.53M
-62.78%-500.31M
-94.82%-307.35M
-202.11%-139.61M
-59.54%-157.76M
---46.21M
Impairment and provision
-98.19%-7.64M
98.52%-26.49M
-5.10%-3.86M
-6,473.38%-1.79B
---3.67M
-241.00%-27.22M
-866.22%-7.98M
-64.36%-2.5M
-139.28%-826K
---1.52M
-Impairment of intangible assets
----
----
----
---1.51B
----
----
----
----
----
----
-Impairment of property, machinery and equipment
----
46.40%-32.75M
----
---61.09M
----
----
----
----
----
----
-Goodwill impairment
----
----
----
---211.44M
----
----
----
----
----
----
-Other impairment is provision
-98.19%-7.64M
249.71%6.26M
-5.10%-3.86M
84.64%-4.18M
---3.67M
-241.00%-27.22M
-866.22%-7.98M
-64.36%-2.5M
-139.28%-826K
---1.52M
Special items of operating profit
-33.58%8.48M
-31.05%31.58M
-34.15%12.77M
29.69%45.8M
--19.39M
-33.02%35.32M
38.49%52.73M
126.16%25.09M
103.92%38.07M
--11.09M
Operating profit
4.73%-123.19M
89.67%-229.92M
55.52%-129.31M
-445.16%-2.23B
-290.72M
31.46%-408.47M
-218.81%-596M
-772.10%-823.11M
199.40%501.63M
122.47M
Financing cost
5.11%-28.47M
-38.70%-60.8M
-56.60%-30M
-70.60%-43.83M
---19.16M
-140.05%-25.69M
32.01%-10.7M
46.05%-5.41M
-46.01%-15.74M
---10.04M
Earning before tax
4.80%-151.66M
87.20%-290.72M
48.59%-159.31M
-422.99%-2.27B
-309.88M
28.44%-434.17M
-224.87%-606.7M
-836.91%-828.53M
209.95%485.89M
112.43M
Tax
11.51%15.66M
-96.18%12.25M
-73.22%14.05M
57.42%320.4M
--52.45M
394.25%203.54M
19.07%-69.17M
-45.23%-34.77M
-131.34%-85.47M
---23.94M
After-tax profit from continuing operations
6.38%-135.99M
85.72%-278.47M
43.57%-145.26M
-745.61%-1.95B
-257.43M
65.88%-230.63M
-268.79%-675.87M
-1,075.54%-863.29M
234.20%400.41M
88.49M
Earning after tax
6.38%-135.99M
85.72%-278.47M
43.57%-145.26M
-745.61%-1.95B
-257.43M
65.88%-230.63M
-268.79%-675.87M
-1,075.54%-863.29M
234.20%400.41M
88.49M
Minority profit
18.84%-4.88M
99.81%-1.24M
14.91%-6.01M
-829.72%-649.24M
---7.06M
426.42%88.97M
-20.00%16.9M
-130.54%-1.44M
777.37%21.13M
--4.73M
Profit attributable to shareholders
5.84%-131.12M
78.69%-277.23M
44.38%-139.25M
-307.07%-1.3B
-250.37M
53.87%-319.6M
-282.65%-692.77M
-1,128.88%-861.85M
223.06%379.29M
83.77M
Basic earnings per share
0.00%-0.11
78.50%-0.23
47.62%-0.11
-296.30%-1.07
-0.21
55.00%-0.27
-253.85%-0.6
-955.56%-0.77
178.57%0.39
0.09
Diluted earnings per share
0.00%-0.11
78.50%-0.23
47.62%-0.11
-296.30%-1.07
-0.21
55.00%-0.27
-253.85%-0.6
-955.56%-0.77
178.57%0.39
0.09
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
Ernst & Young
--
Ernst & Young Accounting Firm
--
(Q6)Jun 30, 2025(FY)Dec 31, 2024(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020
Turnover -4.19%514.66M8.22%1.29B-0.61%537.18M-6.06%1.19B--540.47M-19.49%1.26B-4.14%1.57B26.53%672.56M72.12%1.64B--531.56M
Operating income -4.19%514.66M8.22%1.29B-0.61%537.18M-6.06%1.19B540.47M-19.49%1.26B-4.14%1.57B26.53%672.56M72.12%1.64B531.56M
Cost of sales -16.48%-173.42M-15.73%-331.52M-38.09%-148.89M-21.17%-286.45M---107.82M14.17%-236.41M2.98%-275.43M-16.74%-124.08M-29.74%-283.88M---106.29M
Operating expenses -16.48%-173.42M-15.73%-331.52M-38.09%-148.89M-21.17%-286.45M-107.82M14.17%-236.41M2.98%-275.43M-16.74%-124.08M-29.74%-283.88M-106.29M
Gross profit -12.12%341.24M5.83%953.51M-10.25%388.29M-12.32%901.02M432.65M-20.63%1.03B-4.39%1.29B28.97%548.48M84.77%1.35B425.27M
Selling expenses 0.08%-232.06M-9.85%-542.67M-3.26%-232.24M-0.17%-494M---224.9M-7.18%-493.17M13.71%-460.11M-29.33%-228.83M-61.59%-533.25M---176.94M
Administrative expenses -1.68%-126.25M-11.18%-282.73M-7.35%-124.16M43.59%-254.29M---115.66M61.41%-450.76M-487.82%-1.17B-1,049.55%-1.03B-26.41%-198.7M---89.23M
Research and development expenses 37.12%-106.96M42.94%-363.13M57.32%-170.11M-27.20%-636.4M---398.53M-62.78%-500.31M-94.82%-307.35M-202.11%-139.61M-59.54%-157.76M---46.21M
Impairment and provision -98.19%-7.64M98.52%-26.49M-5.10%-3.86M-6,473.38%-1.79B---3.67M-241.00%-27.22M-866.22%-7.98M-64.36%-2.5M-139.28%-826K---1.52M
-Impairment of intangible assets ---------------1.51B------------------------
-Impairment of property, machinery and equipment ----46.40%-32.75M-------61.09M------------------------
-Goodwill impairment ---------------211.44M------------------------
-Other impairment is provision -98.19%-7.64M249.71%6.26M-5.10%-3.86M84.64%-4.18M---3.67M-241.00%-27.22M-866.22%-7.98M-64.36%-2.5M-139.28%-826K---1.52M
Special items of operating profit -33.58%8.48M-31.05%31.58M-34.15%12.77M29.69%45.8M--19.39M-33.02%35.32M38.49%52.73M126.16%25.09M103.92%38.07M--11.09M
Operating profit 4.73%-123.19M89.67%-229.92M55.52%-129.31M-445.16%-2.23B-290.72M31.46%-408.47M-218.81%-596M-772.10%-823.11M199.40%501.63M122.47M
Financing cost 5.11%-28.47M-38.70%-60.8M-56.60%-30M-70.60%-43.83M---19.16M-140.05%-25.69M32.01%-10.7M46.05%-5.41M-46.01%-15.74M---10.04M
Earning before tax 4.80%-151.66M87.20%-290.72M48.59%-159.31M-422.99%-2.27B-309.88M28.44%-434.17M-224.87%-606.7M-836.91%-828.53M209.95%485.89M112.43M
Tax 11.51%15.66M-96.18%12.25M-73.22%14.05M57.42%320.4M--52.45M394.25%203.54M19.07%-69.17M-45.23%-34.77M-131.34%-85.47M---23.94M
After-tax profit from continuing operations 6.38%-135.99M85.72%-278.47M43.57%-145.26M-745.61%-1.95B-257.43M65.88%-230.63M-268.79%-675.87M-1,075.54%-863.29M234.20%400.41M88.49M
Earning after tax 6.38%-135.99M85.72%-278.47M43.57%-145.26M-745.61%-1.95B-257.43M65.88%-230.63M-268.79%-675.87M-1,075.54%-863.29M234.20%400.41M88.49M
Minority profit 18.84%-4.88M99.81%-1.24M14.91%-6.01M-829.72%-649.24M---7.06M426.42%88.97M-20.00%16.9M-130.54%-1.44M777.37%21.13M--4.73M
Profit attributable to shareholders 5.84%-131.12M78.69%-277.23M44.38%-139.25M-307.07%-1.3B-250.37M53.87%-319.6M-282.65%-692.77M-1,128.88%-861.85M223.06%379.29M83.77M
Basic earnings per share 0.00%-0.1178.50%-0.2347.62%-0.11-296.30%-1.07-0.2155.00%-0.27-253.85%-0.6-955.56%-0.77178.57%0.390.09
Diluted earnings per share 0.00%-0.1178.50%-0.2347.62%-0.11-296.30%-1.07-0.2155.00%-0.27-253.85%-0.6-955.56%-0.77178.57%0.390.09
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified OpinionUnqualified Opinion--Unqualified Opinion--
Auditor --Ernst & Young--Ernst & Young--Ernst & YoungErnst & Young--Ernst & Young Accounting Firm--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
View More
New Consumption Stocks
View More
Hong Kong stocks continue to recover! The Hang Seng Index briefly returned to 26,000 points.
Recently, Hong Kong stocks have rebounded from their lows, with the three major indices continuing their upward momentum. The Hang Seng Inde Show More